The Comprehensive Guide to Patent Reform: The Critical Industry Forum on The Leahy-Smith America Invents Act
23 January 2013
Partner Harold Wegner spoke at the American Conference Institute’s event, The Comprehensive Guide to Patent Reform: The critical industry forum on The Leahy-Smith America Invents Act. His presentation was titled “Preparing Your Company for the Looming Implementation of the First-to-File Regime and Preparing Strategies to Exploit the Coming Changes for Maximum Benefit.”
American Conference Institute’s 2nd Comprehensive Guide to Patent Reform once again unites experienced in-house counsel from top innovators, private practice experts, and senior officials from the USPTO to answer patent professionals’ most pressing questions, including:
- What does “first to file” actually mean under the AIA requirements? Which system can you or should you file under – the current first to invent or the new first to file (or both)? And how do you avoid first-to-file bubble filings before 3/15/2013?
- When can on-sale and public use activity be considered prior art? Has secret §102(f) prior art been eliminated?
- Do you need to include best mode in the application or not and what happens if you don’t? Is best mode completely toothless now? How will examiners be able to address the best mode issue?
- What will be required in the PGR process? What type of discovery? Expert witnesses? How do the estoppel provisions alter your analysis of whether to engage in the PGR system?
- What estoppel provisions are associated with IPRs and how are these different from the inter partes reexamination provisions? When do you file a 3rd party parallel IPR?
For more information, please visit the American Conference Institute’s Web site.
People
Related Insights
21 April 2025
Health Care Law Today
Prescription Drugs: Executive Order Aims to Lower Prices
On April 15, 2025, President Trump signed an executive order (EO) with the aim of reducing the cost of prescription drugs.
21 April 2025
Health Care Law Today
MedTech Round Table: What the Trump Administration Means for Companies and Investors
Foley & Lardner LLP hosted and participated in a MedTech round table of investors and business leaders, including chief executive officers, partners, directors, innovation leads, investment funds managers and partners, and general counsels. There was collective interest in understanding how these MedTech leaders are adjusting to the changing business and regulatory environment under the second Trump administration.
21 April 2025
Labor & Employment Law Perspectives
Supreme Court’s E.M.D. Sales v. Carrera Decision: A Victory for Employers Navigating FLSA Exemptions
In the case at issue, E.M.D. Sales, Inc. v. Carrera, the court clarified the applicable standard of proof, ruling that employers need only demonstrate by a "preponderance of the evidence," the standard used in most civil cases, that an employee qualifies for an FLSA exemption, rather than the higher more stringent "clear and convincing evidence" standard previously applied by the Fourth Circuit Court of Appeals.